MYCN and neuroblastoma: In neuroblastoma, the most common extracranial solid tumor of childhood accounting for approximately 15% of all childhood cancer related deaths, amplification of the MYCN oncogene in tumors represents one of the most powerful prognostic markers yet identified for this malignancy [4].